A ELLIOTT LIMITED
Executive Summary
A Elliott Limited demonstrates improving financial health with positive net current assets and equity after initial losses. However, the company remains small with limited cash reserves and material reliance on a director’s loan, presenting liquidity risks. Conditional credit approval is advised with ongoing monitoring of cash flows, director loan status, and statutory compliance to mitigate risk.
View Full Analysis Report →Company Analysis
This analysis is opinion only and should not be interpreted as financial advice.
A ELLIOTT LIMITED - Analysis Report
Credit Opinion: CONDITIONAL APPROVAL
A Elliott Limited shows improving financial health with positive net current assets and shareholders funds in the most recent year. However, the company is a micro entity with a very small asset base and limited operating scale. The director’s loan balance remains sizeable relative to equity and is interest-free and repayable on demand, which could pose liquidity risk. The absence of employees and reliance on director advances suggest a closely held operation. Approval is recommended with conditions: close monitoring of liquidity, director loan repayment plans, and timely filing of future accounts.Financial Strength:
The balance sheet reflects a modest but positive turnaround. Net current assets improved from a negative £209 in 2023 to positive £3,304 in 2024, driven by stable current assets around £15,800 and a reduction in current liabilities from £15,526 to £12,594. Fixed assets are minimal (£286), consistent with a service-focused specialist medical practice. Shareholders funds rose substantially from £172 to £3,590, indicating accumulated retained earnings or capital injection. Overall, the financial position is fragile but improving.Cash Flow Assessment:
Cash holdings are very low (£70 in 2023, not separately disclosed in 2024 but included in current assets), while debtors balance is high (~£15,200), indicating some reliance on receivables for liquidity. Current liabilities remain significant, though reduced, at £12,594. The working capital position is positive but modest, suggesting limited buffer for unexpected cash flow disruptions. The director’s loan of £7,132 (interest-free, repayable on demand) is a key source of funding but also a risk if repayment is demanded suddenly.Monitoring Points:
- Liquidity trends, especially cash and receivables collection efficiency
- Director loan balance and repayment schedule
- Timeliness and completeness of statutory filings
- Changes in current liabilities and any new short-term obligations
- Any operational changes, including staffing or service offerings affecting revenue stability
- Overall profitability and cash generation from operations in future accounts
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company